David W. Hammers

1.9k total citations
36 papers, 1.3k citations indexed

About

David W. Hammers is a scholar working on Molecular Biology, Genetics and Cell Biology. According to data from OpenAlex, David W. Hammers has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Cell Biology. Recurrent topics in David W. Hammers's work include Muscle Physiology and Disorders (28 papers), Muscle metabolism and nutrition (7 papers) and Mesenchymal stem cell research (6 papers). David W. Hammers is often cited by papers focused on Muscle Physiology and Disorders (28 papers), Muscle metabolism and nutrition (7 papers) and Mesenchymal stem cell research (6 papers). David W. Hammers collaborates with scholars based in United States, Hungary and Germany. David W. Hammers's co-authors include H. Lee Sweeney, Roger P. Farrar, Laura J. Suggs, Elisabeth R. Barton, James Walters, Edward Merritt, Matthew Tierney, Lucas Smith, James J. Hartman and Stefan Engst and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

David W. Hammers

35 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David W. Hammers United States 19 830 359 241 166 165 36 1.3k
Yacine Kharraz Spain 8 830 1.0× 292 0.8× 231 1.0× 50 0.3× 221 1.3× 9 1.2k
Christian Elabd France 14 609 0.7× 341 0.9× 495 2.1× 113 0.7× 455 2.8× 19 1.7k
Zhi Fang China 24 628 0.8× 287 0.8× 187 0.8× 83 0.5× 84 0.5× 50 1.7k
Chiara Rinaldi Italy 13 1.0k 1.2× 342 1.0× 200 0.8× 36 0.2× 327 2.0× 24 1.3k
Laura Barberi Italy 22 1.2k 1.5× 296 0.8× 512 2.1× 66 0.4× 374 2.3× 45 2.1k
Carmine Nicoletti Italy 26 1.7k 2.1× 234 0.7× 461 1.9× 146 0.9× 562 3.4× 53 2.5k
Mitra Lavasani United States 15 570 0.7× 331 0.9× 200 0.8× 68 0.4× 268 1.6× 24 1.1k
Yi Lai United States 21 1.4k 1.7× 323 0.9× 240 1.0× 50 0.3× 93 0.6× 34 1.7k
Keiko Kamakura Japan 26 756 0.9× 197 0.5× 229 1.0× 41 0.2× 135 0.8× 67 2.0k
Arsalan Alizadeh Canada 16 439 0.5× 252 0.7× 99 0.4× 55 0.3× 181 1.1× 25 1.8k

Countries citing papers authored by David W. Hammers

Since Specialization
Citations

This map shows the geographic impact of David W. Hammers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Hammers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Hammers more than expected).

Fields of papers citing papers by David W. Hammers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Hammers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Hammers. The network helps show where David W. Hammers may publish in the future.

Co-authorship network of co-authors of David W. Hammers

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Hammers. A scholar is included among the top collaborators of David W. Hammers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Hammers. David W. Hammers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khattri, Ram B., Abhinandan Batra, Zoe White, et al.. (2024). Comparative lipidomic and metabolomic profiling of mdx and severe mdx-apolipoprotein e-null mice. Skeletal Muscle. 14(1). 36–36.
2.
Lee, Young Il, Jun Xie, Guangping Gao, et al.. (2024). Potential limitations of microdystrophin gene therapy for Duchenne muscular dystrophy. JCI Insight. 9(11). 17 indexed citations
3.
Patsalos, Andreas, László Halász, Xiaoyan Wei, et al.. (2024). Spatiotemporal transcriptomic mapping of regenerative inflammation in skeletal muscle reveals a dynamic multilayered tissue architecture. Journal of Clinical Investigation. 134(20). 6 indexed citations
4.
Neyroud, Daria, Orlando Laitano, Aneesha Dasgupta, et al.. (2023). Blocking muscle wasting via deletion of the muscle-specific E3 ligase MuRF1 impedes pancreatic tumor growth. Communications Biology. 6(1). 519–519. 20 indexed citations
5.
Norris, Alessandra M., David W. McKellar, Marie‐Ange Renault, et al.. (2023). Hedgehog signaling via its ligand DHH acts as cell fate determinant during skeletal muscle regeneration. Nature Communications. 14(1). 3766–3766. 21 indexed citations
6.
Khattri, Ram B., Abhinandan Batra, Michael E. Matheny, et al.. (2022). Magnetic resonance quantification of skeletal muscle lipid infiltration in a humanized mouse model of Duchenne muscular dystrophy. NMR in Biomedicine. 36(3). e4869–e4869. 10 indexed citations
7.
Riley, Lance A., Xiping Zhang, Collin M. Douglas, et al.. (2022). The skeletal muscle circadian clock regulates titin splicing through RBM20. eLife. 11. 13 indexed citations
8.
Hammers, David W.. (2022). NOX4 inhibition promotes the remodeling of dystrophic muscle. JCI Insight. 7(20). 9 indexed citations
9.
Lee, Young Il, et al.. (2022). Evaluation of the DBA/2J mouse as a potential background strain for genetic models of cardiomyopathy. SHILAP Revista de lepidopterología. 1. 100012–100012. 3 indexed citations
10.
Hammers, David W., Michael K. Matheny, Ernest G. Heimsath, et al.. (2021). Filopodia powered by class x myosin promote fusion of mammalian myoblasts. eLife. 10. 9 indexed citations
11.
Hammers, David W., et al.. (2020). The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy. Scientific Reports. 10(1). 14070–14070. 75 indexed citations
12.
Hammers, David W., et al.. (2019). Glucocorticoids counteract hypertrophic effects of myostatin inhibition in dystrophic muscle. JCI Insight. 5(1). 19 indexed citations
13.
Dániel, Bence, Gergely Nagy, Zsolt Czimmerer, et al.. (2018). The Nuclear Receptor PPARγ Controls Progressive Macrophage Polarization as a Ligand-Insensitive Epigenomic Ratchet of Transcriptional Memory. Immunity. 49(4). 615–626.e6. 130 indexed citations
14.
Hammers, David W., et al.. (2017). Supraphysiological levels of GDF 11 induce striated muscle atrophy. EMBO Molecular Medicine. 9(4). 531–544. 98 indexed citations
15.
Liu, Min, David W. Hammers, Elisabeth R. Barton, & H. Lee Sweeney. (2016). Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy. PLoS ONE. 11(11). e0166803–e0166803. 28 indexed citations
16.
Hammers, David W., Margaret M. Sleeper, Sean C. Forbes, et al.. (2016). Disease-modifying effects of orally bioavailable NF-κB inhibitors in dystrophin-deficient muscle. JCI Insight. 1(21). e90341–e90341. 40 indexed citations
17.
Hammers, David W., et al.. (2011). Controlled release of IGF‐I from a biodegradable matrix improves functional recovery of skeletal muscle from ischemia/reperfusion. Biotechnology and Bioengineering. 109(4). 1051–1059. 33 indexed citations
18.
Merritt, Edward, Megan V. Cannon, David W. Hammers, et al.. (2010). Repair of Traumatic Skeletal Muscle Injury with Bone-Marrow-Derived Mesenchymal Stem Cells Seeded on Extracellular Matrix. Tissue Engineering Part A. 16(9). 2871–2881. 121 indexed citations
19.
Hammers, David W., Ronald W. Matheny, Christian Sell, et al.. (2010). Impairment of IGF-I expression and anabolic signaling following ischemia/reperfusion in skeletal muscle of old mice. Experimental Gerontology. 46(4). 265–272. 18 indexed citations
20.
Merritt, Edward, David W. Hammers, Matthew Tierney, et al.. (2009). Functional Assessment of Skeletal Muscle Regeneration Utilizing Homologous Extracellular Matrix as Scaffolding. Tissue Engineering Part A. 16(4). 1395–1405. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yacine Kharraz Breakdown of academic impact, for papers by Christian Elabd Breakdown of academic impact, for papers by Zhi Fang Breakdown of academic impact, for papers by Chiara Rinaldi Breakdown of academic impact, for papers by Laura Barberi Breakdown of academic impact, for papers by Carmine Nicoletti Breakdown of academic impact, for papers by Mitra Lavasani Breakdown of academic impact, for papers by Yi Lai Breakdown of academic impact, for papers by Keiko Kamakura Breakdown of academic impact, for papers by Arsalan Alizadeh
Rankless by CCL
2026